Exhale

The official blog of the Lung Institute.

Interstitial Lung Disease: What is ICD-10?

23 Sep 2016
| Under Interstitial Lung Disease, Lung Disease, Tips | Posted by | 0 Comments
Interstitial Lung Disease: What is ICD-10?

After an interstitial lung disease diagnosis, ICD codes can be confusing. We’re here to make sense of them.

What is ICD-10? In short, it’s an International Classification of Diseases (ICD) diagnosis code. These codes are used to properly note diseases on health records, track epidemiological trends and assist in medical reimbursement decisions. Put forth by the World Health Organization (WHO)—which develops and publishes these ICD codes—national governments and regulatory bodies have recently begun to adopt this system. Although cellular therapy is not yet covered by current insurance options such as HMO’s, Medicare and Medicaid, it’s important to know just what ICD codes such as ICD-10 can mean for you, interstitial lung disease (ILD) and for your future treatment options.

With your health in mind, the Lung Institute is here to give the specifics of ICD codes and breakdown Interstitial Lung Disease: What is ICD-10?

What Is an ICD Code?

As we’ve previously mentioned, an ICD code is a code given by the WHO regarding new and emerging treatments. Split into two systems: ICD-10-CM (Clinical Modification) is used for diagnostic coding and ICD-10-PCS (Procedure Coding System) used for inpatient hospital procedure coding. Today, both systems comprise the newest and most expanded system of disease classification codes, delivering 68,000 codes with the ICD-10-CM edition compared to the previous ICD-9-CM which was only made up of 13,000 codes.

Interstitial Lung Disease: What is ICD-10?

How Does an ICD Code Affect my Interstitial Lung Disease?

To start, it is used to classify an interstitial lung disease diagnosis. This is significantly important to the process of communicating a diagnosis with other medical health providers in order to gain the best treatment recommendations. An ICD code also allows healthcare researchers to track disease trends, which may lead to deeper insights regarding the causes of the disease and which demographic may be most susceptible to it. On a more personal level, an ICD code can be used in conjunction with a CPT (Current Procedural Terminology) code in order to determine billing and medical reimbursements in treatment.

Improve My Quality of Life with Interstitial Lung Disease…

Although an interstitial lung disease prognosis can seem insurmountable, the first step to living a longer life is finding a treatment that addresses the disease head-on. Changing one’s diet and consistently exercising are among the best lifestyle changes one can do aside from quitting smoking. However, if you’re looking to address interstitial lung disease progression directly, it may be time to consider cellular therapy. Rather than only addressing the symptoms of lung disease, cellular therapy directly affects disease progression and can improve quality of life and pulmonary function. For people with lung disease, a change in quality of life could mean the difference between struggling to walk to the mailbox and riding a bike.

If you or a loved one suffers from a chronic disease like ILD, COPD, pulmonary fibrosis or other symptoms of lung disease, the Lung Institute may be able to help with a variety of adult cellular therapy options. Contact us today at (800) 729-3065 to see if you qualify for cellular therapy, and find out what cellular therapy could mean for you.

Interested in our article on Interstitial Lung Disease: What is ICD-10? Share your thoughts and comments below.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.